Tinavi

688277
14.613.44% ( -0.52 )
Delay Closed: Nov 13, 15:00:00

Valuation

Current ValuationThe current P/E ratio is -41.50, within the reasonable range, cheaper than 59.8% of the time in the past 3 years, and the industry ranks 56/65, the industry Median 27.64.

-41.5xP/E
Stock price¥14.61Earnings per share¥-0.35

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 27.64x
014284256

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 27.64x
0x30x60x90x120x150x
P/E ratio
Name/Symbol
300482SZWONDFO BIOTECH
-115.32x621.15%¥7.25B
600055SHWDM
-20.42x--¥7.04B
688277SHTinavi
-41.50x21.95%¥6.81B
300869SZCONTEC
-41.77x--¥3.81B
688212SHAOHUA ENDOSCOPY
-120.88x30.56%¥3.66B
300246SZBIOLIGHT
-30.26x--¥3.56B
002932SZeDiagnosis
-52.58x--¥3.36B
688607SHCareRay
-61.41x--¥3.11B
300753SZAPON
-87.58x--¥2.56B
688576SHXishan Science&Technology
-44.38x--¥2.36B
300165SZSkyray Instrument
-12.62x--¥2.24B
300396SZDIRUI
-11.23x--¥1.96B
301515SZGangtong Medical
-466.79x--¥1.82B
688393SHLBP Medicine
-47.30x--¥1.65B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.